[1] A. P. MacGowan, “Clinical implications of antimicrobial resistance for therapy,” J. Antimicrob. Chemother., vol. 62, no. suppl_2, pp. ii105–ii114, 2008.
[2] M. Frieri, K. Kumar, and A. Boutin, “Antibiotic resistance,” J. Infect. Public Health, vol. 10, no. 4, pp. 369–378, 2017.
[3] E. C. for D. P. and Control, “Antimicrobial resistance surveillance in Europe 2015. annual report of the European antimicrobial resistance surveillance network (EARS-Net),” ECDC, 2015.
[4] N. R. Naylor et al., “Estimating the burden of antimicrobial resistance: a systematic literature review,” Antimicrob. Resist. Infect. Control, vol. 7, pp. 1–17, 2018.
[5] R. N. Al-Zidan, A. S. Saadallah, and G. M. Abdulrazzaq, “The public health dilemma of self-medication with antibiotics: The undergraduate students of the College of Pharmacy in Mosul as an example,” Int. J. Res. Pharm. Sci., vol. 11, no. 3, pp. 3743–3751, 2020.
[6] C. Duicu, I. Cozea, D. Delean, A. A. Aldea, and C. Aldea, “Antibiotic resistance patterns of urinary tract pathogens in children from Central Romania,” Exp. Ther. Med., vol. 22, no. 1, pp. 1–7, 2021.
[7] S. S. Ahmed, A. Shariq, A. A. Alsalloom, I. H. Babikir, and B. N. Alhomoud, “Uropathogens and their antimicrobial resistance patterns: Relationship with urinary tract infections,” Int. J. Health Sci. (Qassim)., vol. 13, no. 2, p. 48, 2019.
[8] A. J. Anejo-Okopi et al., “Prevalence and antibiotic resistance pattern of urinary tract bacterial infections among symptomatic patients attending university of Maiduguri teaching hospital, North East Nigeria,” European Journal of Advanced Research in Biological and Life Sciences, vol. 3, pp. 31-41, 2015.
[9] A. Elkady, P. Sinha, and S. A. Z. Hassan, Infections in pregnancy: an evidence-based approach. Cambridge University Press, 2019.
[10] P. I. Nwanze et al., “Urinary tract infection in Okada village: Prevalence and antimicrobial susceptibility pattern,” Sci Res Essays, vol. 2, no. 4, pp. 112–116, 2007.
[11] J. Schmider et al., “Microbiological characterisation of community-acquired urinary tract infections in Bagamoyo, Tanzania: a prospective study,” Trop. Med. Infect. Dis., vol. 7, no. 6, p. 100, 2022.
[12] T. Mechal, S. Hussen, and M. Desta, “Bacterial profile, antibiotic susceptibility pattern and associated factors among patients attending adult OPD at Hawassa University Comprehensive Specialized Hospital, Hawassa, Ethiopia,” Infect. Drug Resist., 14;14, pp. 99–110, 2021.
[13] J. Hudzicki, “Kirby-Bauer disk diffusion susceptibility test protocol,” Am. Soc. Microbiol., vol. 15, no. 1, pp. 1–23, 2009.
[14] A. Rodloff, T. Bauer, S. Ewig, P. Kujath, and E. Müller, “Susceptible, intermediate, and resistant–the intensity of antibiotic action,” Dtsch. Arztebl. Int., vol. 105, no. 39, p. 657, 2008.
[15] M. M. Al-Jebouri and S. A. Mdish, “Antibiotic resistance pattern of bacteria isolated from patients of urinary tract infections in Iraq,” Open Journal of Urology. Vol.3 No.2, pp. 124-131, 2013.
[16] H. A. Salman, S. M. S. Alsallameh, G. Muhamad, and Z. Taha, “Prevalence of multi-antibiotic resistant bacteria isolated from children with urinary tract infection from Baghdad, Iraq,” Microbiol. Biotechnol. Lett., vol. 50, no. 1, pp. 147–156, 2022.
[17] I. A. Naqid, N. R. Hussein, A. Balatay, K. A. Saeed, and H. A. Ahmed, “Antibiotic susceptibility patterns of uropathogens isolated from female patients with urinary tract infection in Duhok province, Iraq,” Jundishapur J. Heal. Sci., vol. 12, no. 3, 2020.
[18] A. A. van Driel et al., “Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year period,” Eur. J. Clin. Microbiol. Infect. Dis., vol. 38, pp. 2151–2158, 2019.
[19] A. Pormohammad, M. J. Nasiri, and T. Azimi, “Prevalence of antibiotic resistance in Escherichia coli strains simultaneously isolated from humans, animals, food, and the environment: a systematic review and meta-analysis,” Infect. Drug Resist., 8;12, pp. 1181–1197, 2019.
[20] B. Hovelius and P.-A. Mårdh, “Staphylococcus saprophyticus as a common cause of urinary tract infections,” Rev. Infect. Dis., vol. 6, no. 3, pp. 328–337, 1984.
[21] J.-L. Vincent et al., “International study of the prevalence and outcomes of infection in intensive care units,” Jama, vol. 302, no. 21, pp. 2323–2329, 2009.
[22] R. D. Harrington and T. M. Hooton, “Urinary tract infection risk factors and gender.,” J. gender-specific Med. JGSM Off. J. Partnersh. Women’s Heal. Columbia, vol. 3, no. 8, pp. 27–34, 2000.
[23] E. Tacconelli et al., “Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis,” Lancet Infect. Dis., vol. 18, no. 3, pp. 318–327, 2018.
[24] G. M. Knight et al., “Antimicrobial resistance and COVID-19: Intersections and implications,” Elife, vol. 10, p. e64139, 2021.
[25] K. S. Kaye and J. M. Pogue, “Infections caused by resistant gram‐negative bacteria: epidemiology and management,” Pharmacother. J. Hum. Pharmacol. Drug Ther., vol. 35, no. 10, pp. 949–962, 2015.
[26] A. Giedraitienė, A. Vitkauskienė, R. Naginienė, and A. Pavilonis, “Antibiotic resistance mechanisms of clinically important bacteria,” Medicina (B. Aires)., vol. 47, no. 3, p. 19, 2011.
[27] A. A. van Driel, A. E. Muller, R. A. Wijma, E. E. Stobberingh, A. Verbon, and B. C. P. Koch, “Nitrofurantoin for the treatment of uncomplicated urinary tract infection in female patients: the impact of dosing regimen, age, and renal function on drug exposure,” Eur. J. Clin. Pharmacol., vol. 79, no. 8, pp. 1043–1049, 2023.
[28] L. B. Rice, “Antimicrobial resistance in gram-positive bacteria,” Am. J. Infect. Control, vol. 34, no. 5, pp. S11–S19, 2006.
[29] W. M. Sweileh, “Global research publications on irrational use of antimicrobials: call for more research to contain antimicrobial resistance,” Global. Health, vol. 17, no. 1, p. 94, 2021.
)